AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice

Title
AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice
Authors
Keywords
Liver fibrosis, OTC deficiency, AAV, Gene therapy
Journal
MOLECULAR GENETICS AND METABOLISM
Volume 120, Issue 4, Pages 299-305
Publisher
Elsevier BV
Online
2017-03-03
DOI
10.1016/j.ymgme.2017.02.011

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started